Hepatic Vein Thrombosis: An In-Depth Clinical Guide

·

Share

Hepatic vein thrombosis is a blood clot that blocks the veins draining blood out of the liver. When this outflow obstruction causes liver symptoms, it is called Budd-Chiari syndrome. Blood backs up into the liver, which swells, becomes painful, and leaks fluid into the abdomen. It is rare but serious, and most patients have an underlying clotting tendency, most often a blood disorder that has not yet been diagnosed. With early anticoagulation and a stepwise approach to procedures, many patients do well.

Unlike a typical leg clot, this one sits where it can damage a vital organ. That is why a hematologist and a liver specialist usually manage it together.

How Hepatic Vein Thrombosis Affects the Liver

The liver receives blood from the portal vein and hepatic artery and drains it through three main hepatic veins into the inferior vena cava, just below the heart. A clot in these veins, or in the short segment of the vena cava they join, stops blood from leaving.

Pressure then rises inside the liver’s small vessels. The liver becomes congested, oxygen delivery to liver cells falls, and fluid seeps out as ascites. Over time, persistent congestion leads to scarring (fibrosis), which can progress to cirrhosis and portal hypertension. Because clots can extend downward, clinicians often assess for inferior vena cava thrombosis at the same time.

It helps to see where this fits among other venous clots. Our comparison of superficial vs deep vein thrombosis explains why clots in deep and abdominal veins are treated more aggressively than surface clots.

Causes and Risk Factors

In most patients, at least one prothrombotic factor is found, and many have more than one. A full workup is part of hematology care after diagnosis.

Category Examples Why it matters
Myeloproliferative neoplasms Polycythemia vera, essential thrombocythemia, often with a JAK2 mutation The most common underlying cause; may be hidden because blood counts can look near normal
Acquired blood disorders Paroxysmal nocturnal hemoglobinuria (PNH), antiphospholipid syndrome Strong tendency to clot in unusual sites
Inherited thrombophilias Factor V Leiden, prothrombin gene mutation, protein C, protein S, or antithrombin deficiency Raise baseline clotting risk
Hormonal factors Estrogen-containing contraceptives, pregnancy, postpartum period Increase clotting factor levels
Local causes Membranous web of the vena cava, tumors compressing or invading veins, abdominal infection or trauma Directly narrow or damage the outflow veins

Many of these conditions are covered in our guide to clotting disorders. Finding the cause is essential, because it determines how long anticoagulation continues and whether additional treatment is needed.

Signs and Symptoms

The classic combination is abdominal pain, an enlarged liver, and ascites. How these appear depends on how fast the veins block.

Acute and fulminant forms

Sudden, complete blockage causes rapid-onset right upper abdominal pain, a tender enlarged liver, quickly developing ascites, and sometimes jaundice. In the most severe form, the liver fails within days or weeks, with confusion and bleeding problems.

Subacute and chronic forms

Gradual blockage allows small bypass veins to develop, so symptoms creep in over months. Patients may notice abdominal swelling, leg swelling, fatigue, or vague discomfort. Some are diagnosed only after complications of cirrhosis, such as bleeding from enlarged esophageal veins (varices). A few are found incidentally on imaging.

Diagnosis

Doppler ultrasound is the first-line test. It can show absent or reversed flow in the hepatic veins, visible clot, and enlargement of the caudate lobe, a part of the liver that drains separately and often grows to compensate. CT or MRI with contrast confirms the extent of the clot and shows the vena cava and portal vein.

Blood tests include liver function tests, a complete blood count, and coagulation studies. The hematology workup typically adds JAK2 and related mutation testing, flow cytometry for PNH, antiphospholipid antibodies, and inherited thrombophilia testing where appropriate. Hepatic venography, a contrast study performed through a catheter, is usually reserved for planning procedures.

Doctors also distinguish it from conditions that mimic it, such as heart failure, constrictive pericarditis, and sinusoidal obstruction syndrome, where the smallest liver vessels rather than the main hepatic veins are blocked.

Treatment: A Stepwise Approach

Management usually escalates step by step, moving on only when the previous step is not enough.

  1. Anticoagulation for all patients unless there is a strong reason not to. Heparin is usually started first, followed by long-term oral anticoagulation, often a vitamin K antagonist such as warfarin. Anticoagulants do not dissolve the clot; they stop it growing and let the body gradually break it down.
  2. Treat the underlying cause, for example controlling a myeloproliferative neoplasm or treating PNH.
  3. Manage complications such as ascites with diuretics and salt restriction, and screen for varices.
  4. Angioplasty or stenting to reopen a short narrowed segment of a hepatic vein or the vena cava.
  5. TIPS (transjugular intrahepatic portosystemic shunt), a stent through the liver that creates a new outflow channel when veins cannot be reopened.
  6. Liver transplantation for fulminant liver failure or when other measures fail.

Direct oral anticoagulants are used in some patients, but their role in Budd-Chiari syndrome is less established than in leg clots, particularly with advanced liver disease or antiphospholipid syndrome. Anticoagulation is generally continued long term.

When to See a Doctor

Seek urgent medical care for sudden right-sided abdominal pain with rapid swelling of the abdomen, yellowing of the skin or eyes, vomiting blood, or black stools. People with a known myeloproliferative neoplasm, PNH, or a previous clot should report new abdominal swelling promptly rather than waiting for a routine visit.

Frequently Asked Questions

Is hepatic vein thrombosis the same as Budd-Chiari syndrome?

They overlap closely. Budd-Chiari syndrome describes any obstruction of liver outflow, from the small hepatic veins up to where the vena cava meets the heart. Clotting of the hepatic veins is the most common cause, so the terms are often used interchangeably.

Can you recover from hepatic vein thrombosis?

Many patients do, especially when it is diagnosed early and treated with anticoagulation and, if needed, stenting or TIPS. Long-term outcome depends on liver damage at diagnosis and on how well the underlying clotting cause is controlled.

Why is a blood cancer test done after this diagnosis?

Myeloproliferative neoplasms are the most common hidden cause, and blood counts can look deceptively normal because of the enlarged spleen and liver disease. Testing for the JAK2 mutation and related markers finds many of these cases.

Can I become pregnant after Budd-Chiari syndrome?

Pregnancy is possible for some women whose disease is stable, but it raises clotting risk and needs careful planning with a specialist team. Warfarin must be switched to heparin before or early in pregnancy.

Key Takeaways

  • Hepatic vein thrombosis blocks liver outflow and causes pain, liver enlargement, and ascites.
  • Most patients have an underlying clotting disorder, often a myeloproliferative neoplasm.
  • Doppler ultrasound is the first test; CT or MRI confirms.
  • Treatment escalates from anticoagulation to stenting, TIPS, and transplant if needed.
  • For more on clots, see our blood clotting guide.
Written by
Haematology, Platelet Biology
Contact [email protected] AmandaUnsworth1 Website Manchester Metropolitan University June 26, 2020 Repurposing anti-cancer drugs: Could Pim kinase inhibitors be the new aspirin? My scientific interests are in understanding the signalling molecules and pathways that regulate platelet function, thrombosis and haemostasis. My research aims to understand the role platelets play in pathological conditions which is essential for the identification of drug targets,…
View Full Profile →
Web Admin Avatar